// App-Quantinova.ai

3098 : Epigenetic therapy to target neuroendocrine prostate cancer using precision medicine models

Researchers

Presenter

  • Loredana Puca

Principal Investigators

  • Wouter R. Karthaus

  • Dong Gao

  • John Wongvipat

  • Andrea Sboner

  • Marcello Gaudiano

  • Chantal Pauli

  • Rema A. Rao

  • Juan Miguel Mosquera

  • Joanna Cyrta

  • Theresa Y. MacDonald

  • Giorgio Ga Inghirami

  • Yu Chen

  • Mark A. Rubin

  • Himisha Beltran

Medical Centers

  • Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY

  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY

  • Englander Institute for Precision Medicine, New York, NY.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved